Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_assertion type Assertion NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_head.
- NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_assertion description "[The mTOR pathway is an important therapeutic target in vascular tumors, and topical mTOR inhibitors may provide an alternative and well-tolerated therapy for the treatment of cutaneous vascular lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_provenance.
- NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_assertion evidence source_evidence_literature NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_provenance.
- NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_assertion SIO_000772 23938603 NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_provenance.
- NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_assertion wasDerivedFrom befree-20150227 NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_provenance.
- NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_assertion wasGeneratedBy ECO_0000203 NP412107.RAVpJMTqGzGzeYPf85jNEOKsm0pbv3PZ_bxYm6NlKuj2Y130_provenance.